These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management. Pierre JM Drug Saf; 2005; 28(3):191-208. PubMed ID: 15733025 [TBL] [Abstract][Full Text] [Related]
29. Atypical Antipsychotic Use in the Treatment of Psychosis in Primary Care. Leo RJ; Regno PD Prim Care Companion J Clin Psychiatry; 2000 Dec; 2(6):194-204. PubMed ID: 15014629 [TBL] [Abstract][Full Text] [Related]
30. Reversal of haloperidol-induced orofacial dyskinesia by quercetin, a bioflavonoid. Naidu PS; Singh A; Kulkarni SK Psychopharmacology (Berl); 2003 Jun; 167(4):418-23. PubMed ID: 12669184 [TBL] [Abstract][Full Text] [Related]
35. The treatment of tardive dyskinesia and tardive dystonia. Simpson GM J Clin Psychiatry; 2000; 61 Suppl 4():39-44. PubMed ID: 10739330 [TBL] [Abstract][Full Text] [Related]
36. The current status of tardive dyskinesia. Sachdev PS Aust N Z J Psychiatry; 2000 Jun; 34(3):355-69. PubMed ID: 10881961 [TBL] [Abstract][Full Text] [Related]